Geng et al. suggested that fibronectin type III domain containing 5 (FNDC5) alleviates obesity-induced cardiac hypertrophy by inhibiting JAK2/STAT3-related cardiac inflammation and oxidative stress [33]. The gene discussed is FNDC5; the disease is obesity disorder.